Skip to main content

Table 2 SF-36v2 in MD classifications

From: Quality of life in adults with muscular dystrophy

  DMD BMD LGMD FSHD CTRL
Physical Function 1.3 ± 3.5 B**,F**,C*** 18.4 ± 18.2 C*** 6.3 ± 10.3C*** 18.2 ± 12.5 C*** 95.9 ± 9.3
Role Physical 72.1 ± 26.1 F*,C** 53.8 ± 32.5 C*** 59.9 ± 31.5 C*** 41.5 ± 26.7 C*** 99.2 ± 2.1
Bodily Pain 66.1 ± 16.4C* 58.6 ± 22.2C** 56.1 ± 24.4C** 48.1 ± 28.6C*** 87.1 ± 15.8
General Health 55.6 ± 20.1 C** 48.4 ± 19.3 C*** 43.3 ± 22.5 C*** 44.1 ± 24.2 C*** 81.7 ± 11.2
Vitality 63.3 ± 18.0F*** 50.0 ± 24.7C* 51.6 ± 17.3 37.9 ± 16.9C*** 72.3 ± 19.2
Social Function 84.1 ± 41.9C* 68.8 ± 30.4 C** 76.0 ± 27.4 C* 67.9 ± 29.7 C** 97.7 ± 6.8
Role Emotional 80.6 ± 24.5C* 66.2 ± 32.6 C** 86.8 ± 25.7 F* 69.0 ± 24.1 C** 98.4 ± 4.5
Mental Health 79.0 ± 14.9 F* 74.2 ± 16.0 C* 78.8 ± 14.6 65.0 ± 19.1C** 84.7 ± 8.5
Total Physical Score 34.3 ± 5.4 C*** 34.5 ± 6.7 C*** 30.2 ± 5.8 C*** 30.8 ± 6.3 C*** 56.8 ± 3.6
Total Mental Score 58.2 ± 10.5 51.8 ± 9.3 58.3 ± 9.7 49.8 ± 11.0 55.8 ± 3.6
  1. SF36 outcomes. Presented as mean ± SD
  2. DMD Duchenne Muscular Dystrophy, BMD Becker’s Muscular Dystrophy, LGMD Limb-Girdle Muscular Dystrophy, FSHD Facioscapulohumeral Muscular Dystrophy; B denotes significant difference from BMD; LG denotes significant difference from LGMD; F denotes significant difference from FSHD; C denotes significant difference from CTRL; * denotes significance <.05; ** denotes significance <.01; *** denotes significance <.001